Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prokinetics for Feed Intolerance in Critically Ill Cirrhosis
NCT02528760Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Sep 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of metoclopramide and erythromycin in feeding intolerance (3 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Resolution of feed intolerance at 24 hours. Started Sep 2015; status: completed.
02
Drugs
metoclopramideerythromycin
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on NCT02528760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02528760.